These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 21086786)

  • 1. The relationship between methylation of the Syk gene in the promoter region and the genesis of lung cancer.
    Ma L; Dong S; Zhang P; Xu N; Yan H; Liu H; Li Y; Zhou Q
    Clin Lab; 2010; 56(9-10):407-16. PubMed ID: 21086786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Research on the reactivation of Syk expression caused by the inhibition of DNA promoter methylation in the lung cancer.
    Dong SW; Ma L; Xu N; Yan HQ; Liu HY; Li YW; Zhang P
    Neoplasma; 2011; 58(1):89-95. PubMed ID: 21067271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hypermethylation of syk gene in promoter region is associated with oncogenesis, metastasis of breast carcinoma].
    Ding YB; Wu ZY; Wang S; Zha XM; Zheng W; Liu XA; Fan P
    Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):290-3. PubMed ID: 15059510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased expression of retinoblastoma protein-interacting zinc-finger gene 1 in human esophageal squamous cell cancer by DNA methylation.
    Dong SW; Cui YT; Zhong RR; Liang DC; Liu YM; Wang YG; He Z; Wang S; Liang SJ; Zhang P
    Clin Lab; 2012; 58(1-2):41-51. PubMed ID: 22372344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypermethylation of Syk gene in promoter region associated with oncogenesis and metastasis of gastric carcinoma.
    Wang S; Ding YB; Chen GY; Xia JG; Wu ZY
    World J Gastroenterol; 2004 Jun; 10(12):1815-8. PubMed ID: 15188513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-aza-CdR induces the demethylation of Syk promoter in nasopharyngeal carcinoma cell.
    Jin Q; Liu C; Yan C; Tao B; Li Z; Cai Z
    Gene; 2012 Dec; 511(2):224-6. PubMed ID: 23036706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
    Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
    Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent epigenetic inactivation of spleen tyrosine kinase gene in human hepatocellular carcinoma.
    Yuan Y; Wang J; Li J; Wang L; Li M; Yang Z; Zhang C; Dai JL
    Clin Cancer Res; 2006 Nov; 12(22):6687-95. PubMed ID: 17121887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of spleen tyrosine kinase expression re-activation by inhibition of DNA methylation on oncogenesis growth of gastric cancer].
    Ding YB; Xia JG; Chen GY
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Nov; 9(6):523-6. PubMed ID: 17143801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypermethylation leads to silencing of the SYK gene in human breast cancer.
    Yuan Y; Mendez R; Sahin A; Dai JL
    Cancer Res; 2001 Jul; 61(14):5558-61. PubMed ID: 11454707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivation of SYK expression by inhibition of DNA methylation suppresses breast cancer cell invasiveness.
    Yuan Y; Liu H; Sahin A; Dai JL
    Int J Cancer; 2005 Feb; 113(4):654-9. PubMed ID: 15455373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas.
    Kunze E; Wendt M; Schlott T
    Int J Mol Med; 2006 Oct; 18(4):547-57. PubMed ID: 16964403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and methylation status of the Syk gene in cervical carcinoma.
    Zhao S; Sun G; Tony PW; Ma D; Zhao C
    Arch Gynecol Obstet; 2011 May; 283(5):1113-9. PubMed ID: 20563729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between promoter methylation of Syk and Runx3 genes and postoperative recurrence and metastasis in gastric carcinoma].
    Hong H; Zhou K; Fu P; Huang Q; Wang J; Yuan X; Li J
    Zhonghua Zhong Liu Za Zhi; 2014 May; 36(5):341-5. PubMed ID: 25030588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypermethylation of the spleen tyrosine kinase promoter in T-lineage acute lymphoblastic leukemia.
    Goodman PA; Burkhardt N; Juran B; Tibbles HE; Uckun FM
    Oncogene; 2003 Apr; 22(16):2504-14. PubMed ID: 12717427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypermethylation of the GATA genes in lung cancer.
    Guo M; Akiyama Y; House MG; Hooker CM; Heath E; Gabrielson E; Yang SC; Han Y; Baylin SB; Herman JG; Brock MV
    Clin Cancer Res; 2004 Dec; 10(23):7917-24. PubMed ID: 15585625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosis.
    Miao Y; Wang L; Zhang X; Xu X; Jiang G; Fan C; Liu Y; Lin X; Yu J; Zhang Y; Wang E
    PLoS One; 2014; 9(11):e112258. PubMed ID: 25396757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spleen tyrosine kinase as a novel candidate tumor suppressor gene for human oral squamous cell carcinoma.
    Ogane S; Onda T; Takano N; Yajima T; Uchiyama T; Shibahara T
    Int J Cancer; 2009 Jun; 124(11):2651-7. PubMed ID: 19195024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The correlation between aberrant connexin 43 mRNA expression induced by promoter methylation and nodal micrometastasis in non-small cell lung cancer.
    Chen JT; Cheng YW; Chou MC; Sen-Lin T; Lai WW; Ho WL; Lee H
    Clin Cancer Res; 2003 Sep; 9(11):4200-4. PubMed ID: 14519646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent inactivation of RAMP2, EFEMP1 and Dutt1 in lung cancer by promoter hypermethylation.
    Yue W; Dacic S; Sun Q; Landreneau R; Guo M; Zhou W; Siegfried JM; Yu J; Zhang L
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4336-44. PubMed ID: 17671114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.